| Jonathan Eitan Miller, MD | |
|
600 N Wolfe St, Baltimore, MD 21287-0005 | |
| (410) 955-9441 | |
| Not Available |
| Full Name | Jonathan Eitan Miller |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 600 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114452505 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | D97096 (Maryland) | Primary |
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study published in the February issue of Radiology.
On the eve of World AIDS Day 2009, AIDS Healthcare Foundation (AHF) praised the World Health Organization (WHO) for its new HIV treatment recommendations which include starting lifesaving antiretroviral treatment (ART) earlier (at a t-cell count of <350 cells/mm3 instead of <200) for all HIV-positive adults and adolescents and earlier treatment initiation for HIV-positive pregnant women who should now begin treatment at 14 weeks into pregnancy, rather than 28 weeks as previously recommended, and continue until the end of breastfeeding.
Researchers from Boston University School of Medicine (BUSM) have estimated that one in six women are at risk for developing Alzheimer's disease (AD) in their lifetime, while the risk for men is one in ten.
Results of a study presented today at the International Liver Congress 2010 demonstrate that a dual FXR and TGR5 agonist decreases liver damage and modulates hepatic inflammation and fibrosis in a mouse model of primary sclerosing chlolangitis. In contrast, selective FXR or TGR5 agonists have no beneficial effect.
In a startling discovery that raises fundamental questions about human behavior, researchers at the University of Virginia School of Medicine have determined that the immune system directly affects - and even controls - creatures' social behavior, such as their desire to interact with others.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Eitan Miller, MD 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: () - | Jonathan Eitan Miller, MD 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-9441 |
News Archive
A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study published in the February issue of Radiology.
On the eve of World AIDS Day 2009, AIDS Healthcare Foundation (AHF) praised the World Health Organization (WHO) for its new HIV treatment recommendations which include starting lifesaving antiretroviral treatment (ART) earlier (at a t-cell count of <350 cells/mm3 instead of <200) for all HIV-positive adults and adolescents and earlier treatment initiation for HIV-positive pregnant women who should now begin treatment at 14 weeks into pregnancy, rather than 28 weeks as previously recommended, and continue until the end of breastfeeding.
Researchers from Boston University School of Medicine (BUSM) have estimated that one in six women are at risk for developing Alzheimer's disease (AD) in their lifetime, while the risk for men is one in ten.
Results of a study presented today at the International Liver Congress 2010 demonstrate that a dual FXR and TGR5 agonist decreases liver damage and modulates hepatic inflammation and fibrosis in a mouse model of primary sclerosing chlolangitis. In contrast, selective FXR or TGR5 agonists have no beneficial effect.
In a startling discovery that raises fundamental questions about human behavior, researchers at the University of Virginia School of Medicine have determined that the immune system directly affects - and even controls - creatures' social behavior, such as their desire to interact with others.
› Verified 8 days ago
Derek Lee Masden, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, Baltimore, MD 21218 Phone: 585-233-9659 | |
Dr. Bao-quynh Thuy Julian, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St # 8161, Baltimore, MD 21287 Phone: 443-997-9466 Fax: 410-614-4333 | |
Dr. Joseph C Orlando, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5601 Loch Raven Blvd, Suite 101, Pob, Baltimore, MD 21239 Phone: 410-433-4300 Fax: 410-433-4491 | |
Kerry Elizabeth Owens, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Frederick Rd, Suite 200, Baltimore, MD 21228 Phone: 410-744-0900 Fax: 410-744-3160 | |
Dr. James P. Higgins, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, 2nd Fl, Baltimore, MD 21218 Phone: 410-235-5405 | |
Maakan Taghizadeh, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 Frederick Rd, Suite 200, Baltimore, MD 21228 Phone: 410-744-0900 Fax: 410-744-3160 |